中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
Chinese Journal of Experimental Surgery
2015年
9期
2085-2087
,共3页
邓一帆%祝刚%黄小山%李百升%秦忠宗
鄧一帆%祝剛%黃小山%李百升%秦忠宗
산일범%축강%황소산%리백승%진충종
胶质母细胞瘤%胶质母细胞瘤干细胞%微小RNA-203%细胞增殖
膠質母細胞瘤%膠質母細胞瘤榦細胞%微小RNA-203%細胞增殖
효질모세포류%효질모세포류간세포%미소RNA-203%세포증식
Glioblastoma multiforme%Glioblastoma stem cells%MicroRNA-203%Cell proliferation
目的 培养胶质母细胞瘤干细胞,检测微小RNA-203(miR-203)在胶质母细胞瘤干细胞中的表达,并观察其对肿瘤干细胞增殖的影响.方法 对胶质母细胞瘤组织行体外原代培养,以CD133为标志物,免疫磁珠法分选胶质母细胞瘤干细胞;免疫荧光染色检测分选所得细胞的CD133、巢蛋白(nestin)、神经胶质纤维酸性蛋白(GFAP)、微管相关蛋白2(MAP2)的表达,从而鉴定肿瘤干细胞.反转录-聚合酶链反应(RT-PCR)检测分选后CD133+细胞、CD133-细胞miR-203的表达;将miR-203模拟体和无意义寡核苷酸链(NC)分别转染胶质母细胞瘤干细胞作为miR-203、NC组,细胞计数试剂盒(CCK-8)法检测转染后24、48、72、96、120 h细胞生存率;流式细胞仪细胞检测转染后3d细胞凋亡率.结果 培养的胶质母细胞瘤干细胞成球样生长,表达干细胞标志物CD133、Nestin,分化后细胞表达星形胶质细胞的标志物GFAP、神经元的标志物MAP2;分选后CD133+细胞中miR-203的表达低于CD133-细胞;转染miR-203后24、48、72、96、120 h组的细胞生存率均降低,差异有统计学意义(P<0.05);流式细胞仪检测显示miR-203组的细胞凋亡率为(9.74±2.81)%,高于NC组的(3.95±0.91)%,差异有统计学意义(P<0.05).结论 上调miR-203可能成为针对胶质母细胞瘤干细胞的基因治疗策略.
目的 培養膠質母細胞瘤榦細胞,檢測微小RNA-203(miR-203)在膠質母細胞瘤榦細胞中的錶達,併觀察其對腫瘤榦細胞增殖的影響.方法 對膠質母細胞瘤組織行體外原代培養,以CD133為標誌物,免疫磁珠法分選膠質母細胞瘤榦細胞;免疫熒光染色檢測分選所得細胞的CD133、巢蛋白(nestin)、神經膠質纖維痠性蛋白(GFAP)、微管相關蛋白2(MAP2)的錶達,從而鑒定腫瘤榦細胞.反轉錄-聚閤酶鏈反應(RT-PCR)檢測分選後CD133+細胞、CD133-細胞miR-203的錶達;將miR-203模擬體和無意義寡覈苷痠鏈(NC)分彆轉染膠質母細胞瘤榦細胞作為miR-203、NC組,細胞計數試劑盒(CCK-8)法檢測轉染後24、48、72、96、120 h細胞生存率;流式細胞儀細胞檢測轉染後3d細胞凋亡率.結果 培養的膠質母細胞瘤榦細胞成毬樣生長,錶達榦細胞標誌物CD133、Nestin,分化後細胞錶達星形膠質細胞的標誌物GFAP、神經元的標誌物MAP2;分選後CD133+細胞中miR-203的錶達低于CD133-細胞;轉染miR-203後24、48、72、96、120 h組的細胞生存率均降低,差異有統計學意義(P<0.05);流式細胞儀檢測顯示miR-203組的細胞凋亡率為(9.74±2.81)%,高于NC組的(3.95±0.91)%,差異有統計學意義(P<0.05).結論 上調miR-203可能成為針對膠質母細胞瘤榦細胞的基因治療策略.
목적 배양효질모세포류간세포,검측미소RNA-203(miR-203)재효질모세포류간세포중적표체,병관찰기대종류간세포증식적영향.방법 대효질모세포류조직행체외원대배양,이CD133위표지물,면역자주법분선효질모세포류간세포;면역형광염색검측분선소득세포적CD133、소단백(nestin)、신경효질섬유산성단백(GFAP)、미관상관단백2(MAP2)적표체,종이감정종류간세포.반전록-취합매련반응(RT-PCR)검측분선후CD133+세포、CD133-세포miR-203적표체;장miR-203모의체화무의의과핵감산련(NC)분별전염효질모세포류간세포작위miR-203、NC조,세포계수시제합(CCK-8)법검측전염후24、48、72、96、120 h세포생존솔;류식세포의세포검측전염후3d세포조망솔.결과 배양적효질모세포류간세포성구양생장,표체간세포표지물CD133、Nestin,분화후세포표체성형효질세포적표지물GFAP、신경원적표지물MAP2;분선후CD133+세포중miR-203적표체저우CD133-세포;전염miR-203후24、48、72、96、120 h조적세포생존솔균강저,차이유통계학의의(P<0.05);류식세포의검측현시miR-203조적세포조망솔위(9.74±2.81)%,고우NC조적(3.95±0.91)%,차이유통계학의의(P<0.05).결론 상조miR-203가능성위침대효질모세포류간세포적기인치료책략.
Objective To isolate glioblastoma multiforme stem cells (GBM-SCs) from glioblastoma multiforme (GBM) specimens and to investigate the expression of microRNA (miR)-203 in GBM stem cells and its impact on cell proliferation.Methods CD133 + cells were separated using magnetic cell sorting technique (MACS) after primary culture.Reverse transcription-polymerase chain reaction (RT-PCR) was used to analyze miR-203 expression in CD133 + cells.Lipofectamine RNAiMAX was used to transfect miR-203 mimic and scrambled control oligonucleotides into GBM-SCs.The proliferation ability of miR-203 treated GBM-SCs was determined by CCK-8 and the apoptosis ratio was detected by cell flow cytometry.Results GBM-SCs isolated from GBM specimens formed GBM spheres,expressed markers associated with neural stem cells,and possessed the capacity for self-renewal and multilineage differentiation.MiR-203 expression was down-regulated in CD133+ cells relative to CD133-cells.MiR-203 can repress GBM-SCs growth and induce apoptosis.Conclusion Reactivation of miR-203 expression suggests novel therapeutic strategies for GBM-SCs.